title: In silico mechanistic profiling to probe small molecule binding to sulfotransferases.
abstract: Drug metabolizing enzymes play a key role in the metabolism, elimination and detoxification of xenobiotics, drugs and endogenous molecules. While their principal role is to detoxify organisms by modifying compounds, such as pollutants or drugs, for a rapid excretion, in some cases they render their substrates more toxic thereby inducing severe side effects and adverse drug reactions, or their inhibition can lead to drug-drug interactions. We focus on sulfotransferases (SULTs), a family of phase II metabolizing enzymes, acting on a large number of drugs and hormones and showing important structural flexibility. Here we report a novel in silico structure-based approach to probe ligand binding to SULTs. We explored the flexibility of SULTs by molecular dynamics (MD) simulations in order to identify the most suitable multiple receptor conformations for ligand binding prediction. Then, we employed structure-based docking-scoring approach to predict ligand binding and finally we combined the predicted interaction energies by using a QSAR methodology. The results showed that our protocol successfully prioritizes potent binders for the studied here SULT1 isoforms, and give new insights on specific molecular mechanisms for diverse ligands' binding related to their binding sites plasticity. Our best QSAR models, introducing predicted protein-ligand interaction energy by using docking, showed accuracy of 67.28%, 78.00% and 75.46%, for the isoforms SULT1A1, SULT1A3 and SULT1E1, respectively. To the best of our knowledge our protocol is the first in silico structure-based approach consisting of a protein-ligand interaction analysis at atomic level that considers both ligand and enzyme flexibility, along with a QSAR approach, to identify small molecules that can interact with II phase dug metabolizing enzymes.
authors.affiliation: Université Paris Diderot, Sorbonne Paris Cité, Molécules Thérapeutiques In Silico, INSERM UMR-S 973, Paris, France ; INSERM, U973, Paris, France.
authors.forename: Virginie Y
authors.initials: VY
authors.lastname: Martiny
authors.forename: Pablo
authors.initials: P
authors.lastname: Carbonell
authors.forename: David
authors.initials: D
authors.lastname: Lagorce
authors.forename: Bruno O
authors.initials: BO
authors.lastname: Villoutreix
authors.forename: Gautier
authors.initials: G
authors.lastname: Moroy
authors.forename: Maria A
authors.initials: MA
authors.lastname: Miteva
mesh_terms: D015239:Arylsulfotransferase / Q000737:chemistry / Q000378:metabolism; D001665:Binding Sites; D003198:Computer Simulation; D018360:Crystallography, X-Ray; D006801:Humans; D008024:Ligands; D008958:Models, Molecular; D056004:Molecular Dynamics Simulation; D015394:Molecular Structure; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D021281:Quantitative Structure-Activity Relationship; D054852:Small Molecule Libraries / Q000737:chemistry* / Q000378:metabolism; D015238:Sulfotransferases / Q000737:chemistry* / Q000378:metabolism; D013816:Thermodynamics; D015262:Xenobiotics / Q000737:chemistry* / Q000378:metabolism
chemical_list: D008024:Ligands; D054852:Small Molecule Libraries; D015262:Xenobiotics; D015238:Sulfotransferases; D015239:Arylsulfotransferase; C117544:SULT1A1 protein, human; C403170:monoamine-sulfating phenol sulfotransferase; C020122:estrone sulfotransferase
references.citation: J Comput Chem. 2008 Apr 15;29(5):701-15
references.pmid: 17918282
references.citation: Nat Biotechnol. 2009 Nov;27(11):1050-5
references.pmid: 19855396
references.citation: J Biol Chem. 2005 Dec 16;280(50):41482-6
references.pmid: 16221673
references.citation: Nucleic Acids Res. 2000 Jan 1;28(1):235-42
references.pmid: 10592235
references.citation: J Biol Chem. 2003 Feb 28;278(9):7655-62
references.pmid: 12471039
references.citation: Future Med Chem. 2009 Jul;1(4):645-65
references.pmid: 21426031
references.citation: J Chem Inf Model. 2010 Jun 28;50(6):961-78
references.pmid: 20527756
references.citation: PLoS Biol. 2007 May;5(5):e97
references.pmid: 17425406
references.citation: PLoS One. 2011;6(11):e26794
references.pmid: 22069470
references.citation: Mol Pharm. 2012 Apr 2;9(4):862-73
references.pmid: 22352375
references.citation: Curr Pharm Des. 2012;18(9):1266-91
references.pmid: 22316153
references.citation: BMC Struct Biol. 2011 May 12;11:24
references.pmid: 21569443
references.citation: J Appl Toxicol. 2012 Oct;32(10):751-5
references.pmid: 22678655
references.citation: J Comput Aided Mol Des. 2006 Oct-Nov;20(10-11):601-19
references.pmid: 17149653
references.citation: Methods Enzymol. 2005;400:249-63
references.pmid: 16399353
references.citation: Chem Biol Interact. 1998 Feb 20;109(1-3):221-35
references.pmid: 9566747
references.citation: Eur Biophys J. 2010 Aug;39(9):1365-72
references.pmid: 20237920
references.citation: Chem Res Toxicol. 2011 Oct 17;24(10):1720-8
references.pmid: 21913674
references.citation: J Comput Chem. 2004 Aug;25(11):1400-15
references.pmid: 15185334
references.citation: J Chem Inf Model. 2005 Jan-Feb;45(1):160-9
references.pmid: 15667141
references.citation: Angew Chem Int Ed Engl. 2004 Jul 5;43(27):3526-48
references.pmid: 15293241
references.citation: J Mol Biol. 1997 Apr 4;267(3):727-48
references.pmid: 9126849
references.citation: Expert Opin Drug Metab Toxicol. 2010 Jul;6(7):851-61
references.pmid: 20565339
references.citation: J Chem Inf Model. 2009 Sep;49(9):2082-91
references.pmid: 19702241
references.citation: Methods Mol Biol. 2011;719:153-72
references.pmid: 21370083
references.citation: J Chem Inf Comput Sci. 2003 Sep-Oct;43(5):1563-9
references.pmid: 14502490
references.citation: J Struct Funct Genomics. 2009 Apr;10(2):181-91
references.pmid: 19194785
references.citation: Curr Opin Chem Biol. 2008 Oct;12(5):573-81
references.pmid: 18625336
references.citation: Curr Pharm Des. 2011;17(17):1663-71
references.pmid: 21619526
references.citation: J Comput Chem. 2009 Dec;30(16):2785-91
references.pmid: 19399780
references.citation: Nucleic Acids Res. 2011 Jan;39(Database issue):D670-6
references.pmid: 21062828
references.citation: Bioinformatics. 2011 Jul 15;27(14):2018-20
references.pmid: 21636592
references.citation: J Chem Inf Model. 2012 Feb 27;52(2):360-72
references.pmid: 22148551
references.citation: Altern Lab Anim. 2009 Nov;37(5):477-96
references.pmid: 20017578
references.citation: J Phys Chem B. 1998 Apr 30;102(18):3586-616
references.pmid: 24889800
references.citation: Drug Metab Pharmacokinet. 2006 Aug;21(4):257-76
references.pmid: 16946553
references.citation: J Med Chem. 2008 Feb 28;51(4):817-34
references.pmid: 18232648
references.citation: Drug Discov Today. 2012 Jan;17(1-2):44-55
references.pmid: 22056716
references.citation: J Chem Inf Model. 2013 Apr 22;53(4):887-97
references.pmid: 23527586
references.citation: J Mol Biol. 1999 Oct 29;293(3):521-30
references.pmid: 10543947
references.citation: Biochemistry. 2013 Jan 15;52(2):415-24
references.pmid: 23256751
references.citation: J Comput Chem. 2010 Jan 30;31(2):455-61
references.pmid: 19499576
references.citation: J Biol Chem. 1998 Oct 16;273(42):27325-30
references.pmid: 9765259
references.citation: Bioinformatics. 2007 Jan 15;23(2):e104-9
references.pmid: 17237076
references.citation: Mol Cell Endocrinol. 2010 Apr 12;317(1-2):127-40
references.pmid: 20025931
references.citation: Environ Health Perspect. 2003 Jun;111(7):884-8
references.pmid: 12782487
references.citation: Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W372-5
references.pmid: 15980492
references.citation: Chem Biol. 2012 Jan 27;19(1):29-41
references.pmid: 22284352
references.citation: J Comput Chem. 2011 Aug;32(11):2359-68
references.pmid: 21541964
references.citation: Drug Metab Dispos. 2003 Sep;31(9):1187-97
references.pmid: 12920175
references.citation: Curr Opin Struct Biol. 2011 Apr;21(2):189-99
references.pmid: 21292475
references.citation: Methods Mol Biol. 2011;685:155-74
references.pmid: 20981523
references.citation: Expert Opin Drug Metab Toxicol. 2012 Jun;8(6):635-46
references.pmid: 22512672
references.citation: Toxicol Sci. 2006 Mar;90(1):5-22
references.pmid: 16322073
references.citation: Mol Pharm. 2011 Aug 1;8(4):1332-41
references.pmid: 21707071
references.citation: Expert Opin Drug Metab Toxicol. 2011 Dec;7(12):1497-511
references.pmid: 22050465
references.citation: Drug Metab Dispos. 2012 Aug;40(8):1588-95
references.pmid: 22593037
references.citation: Drug Discov Today. 2011 Jun;16(11-12):530-8
references.pmid: 21554979
references.citation: Drug Discov Today. 2012 Jun;17(11-12):549-60
references.pmid: 22305937
references.citation: Biochem Biophys Res Commun. 2005 Sep 23;335(2):417-23
references.pmid: 16083857
references.citation: Expert Opin Drug Metab Toxicol. 2007 Oct;3(5):641-65
references.pmid: 17916053
references.citation: Chem Biol Drug Des. 2010 Jan;75(1):3-17
references.pmid: 19878193
references.citation: J Chem Inf Model. 2012 Jun 25;52(6):1413-37
references.pmid: 22582859
references.citation: Drug Discov Today. 2010 Jan;15(1-2):16-22
references.pmid: 19835978
references.citation: Nat Rev Drug Discov. 2003 Jul;2(7):527-41
references.pmid: 12838268
references.citation: J Chem Inf Model. 2009 Mar;49(3):716-25
references.pmid: 19434904
references.citation: Protein Sci. 1998 Sep;7(9):1884-97
references.pmid: 9761470
references.citation: J Mol Biol. 1982 Jun 5;157(4):671-9
references.pmid: 6288964